Global expression of molecular transporters in the human vaginal tract: implications for HIV chemoprophylaxis.
Global expression of molecular transporters in the human vaginal tract: implications for HIV chemoprophylaxis.
复制标题
DOI:
10.1371/journal.pone.0077340
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Baum MM
中科院分区:
文献类型:
--
作者:
Gunawardana M;Mullen M;Moss JA;Pyles RB;Nusbaum RJ;Patel J;Vincent KL;Wang C;Guo C;Yuan YC;Warden CD;Baum MM
Pre-exposure chemoprophylaxis (PrECP) using antiretroviral agents is a promising strategy for the prevention of sexual HIV transmission in women. Molecular transporters in the human vaginal tract (VT) may play a pivotal role in determining drug disposition and, consequently, pharmacodynamic outcomes in these efforts. Little is known, however, on the expression of these transporters in vaginal tissues, representing a critical knowledge gap. Our study analyzed the genome-wide transcriptome in 44 vaginal tissue samples from 6 reproductive-age women undergoing gynecologic surgeries. The analysis revealed that, unexpectedly, a large number (43%) of gene isoforms corresponding to membrane transporters were over-expressed (above the median expression level) in all samples. A subset of 12 highly expressed membrane transporters was identified and contained 10 members (83%) of the solute carrier superfamily. The largest difference in membrane transporter gene expression was observed across subjects, but more subtle differential expression also was found along the anterior-posterior axis of the VT. Cross-validation of the microarray analyses with measurements RT-qPCR demonstrated high concordance between these data sets. Immunofluorescence labeling of membrane transporter proteins in vaginal tissues was highly dependent on tissue/cell types. Antiretroviral PrECP drugs currently under evaluation are substrates for molecular transporters that were commonly expressed, but fell into both over- or under-expressed categories in all samples, suggesting a complex role for carrier-mediated processes in determining the disposition of these xenobiotics in vaginal tissues. These findings hold important implications for the successful development of products, either oral or intravaginal, for female-controlled HIV PrECP.
登录
查看更多内容
影响因子:
2.3
作者:
Janoria, Kumar G.;Boddu, Sai H. S.;Mitra, Ashim K.
通讯作者:
Mitra, Ashim K.
影响因子:
2
作者:
Anand, BS;Katragadda, S;Mitra, AK
通讯作者:
Mitra, AK
影响因子:
5.8
作者:
Jain, R;Agarwal, S;Mitra, AK
通讯作者:
Mitra, AK
DOI:
10.1111/j.2517-6161.1995.tb02031.x
发表时间:
1995-01-01
影响因子:
5.8
作者:
BENJAMINI, Y;HOCHBERG, Y
通讯作者:
HOCHBERG, Y
影响因子:
5.2
作者:
Ford, J;Khoo, SH;Back, DJ
通讯作者:
Back, DJ